Alder BioPharma (ALDR) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ALDR Hot Sheet
Join SI Premium – FREE
Alder BioPharma (NASDAQ: ALDR) reported Q2 EPS of ($0.79), $0.04 worse than the analyst estimate of ($0.75).
For earnings history and earnings-related data on Alder BioPharma (ALDR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Growth isn't weak enough to truly undercut inflation pressures - BMO
- BancFirst Corp. (BANF) Tops Q1 EPS by 11c
- Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
